Head and Neck Cancer

A Phase II Randomized Trial of Transoral Surgical Resection Followed by Low-dose or Standard-dose IMRT in Resectable p16+ Locally Advanced Oropharynx Cancer
Disease/Condition: Lip, Oral Cavity and Pharynx
Principal Investigator: Benjamin Judson
A Phase III Randomized Trial of MK-3475 (Pembrolizumab) Versus Standard Treatment in Subjects With Recurrent or Metastatic Head and Neck Cancer
Disease/Condition: Stomach
Principal Investigator: Barbara Burtness
A Pilot Study to Assess the Activity of Demethylation Therapy in Patients With HPV Positive Compared With HPV Negative Head and Neck Squamous Cell Carcinoma (HNSCC)
Principal Investigator: Hari Deshpande
A Randomized Phase II Study of Topical Steroids as Preemptive Therapy for EGFR Inhibitor-Induced Papulopustular Eruption
Disease/Condition: Other Skin
Principal Investigator: Jennifer Choi
A Randomized Phase II/III Trial of Surgery and Postoperative Radiation Delivered With Concurrent Cisplatin Versus Docetaxel Versus Docetaxel and Cetuximab for High-Risk Squamous Cell Cancer of the Head and Neck (RTOG 1216)
Principal Investigator: Roy Decker
A Randomized, Double-Blind, Placebo-Controlled, Phase III Study to Evaluate the Efficacy and Safety of Afatinib (BIBW 2992) as Adjuvant Therapy After Chemo-Radiotherapy in Primary Unresected Patients with Stage III, IVa, or IVb Loco-Regionally Advanced Head and Neck Squamous Cell Carcinoma
Disease/Condition: Brain and Nervous System | Other Respiratory and Intrathoracic Organs
Principal Investigator: Anne Chiang